Alto Neuroscience (ANRO) Convertible Debt (2024 - 2026)
Alto Neuroscience (ANRO) posted Convertible Debt of $2.3 million for Q1 2026, up 4.85% sequentially from $2.2 million in Q4 2025, and up 92.82% YoY from $1.2 million in Q1 2025.
Alto Neuroscience (ANRO) Convertible Debt (2024 - 2026) Analysis & Trends
Alto Neuroscience has reported Convertible Debt for 3 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Convertible Debt rose 92.82% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 92.82% YoY) and the FY2025 annual result came in at $2.2 million, up 70.78% from the prior year.
- Convertible Debt climbed to $2.3 million in Q1 2026 per ANRO's latest filing, from $2.2 million in the prior quarter.
- Over five years, Convertible Debt peaked at $2.3 million in Q1 2026 and troughed at $1.2 million in Q1 2025.
- A 3-year average of $1.8 million and a median of $2.0 million in 2025 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2025 and 2026: Convertible Debt surged 63.64% in 2025, then jumped 92.82% in 2026.
- Over 3 years, Convertible Debt stood at $1.3 million in 2024, then surged by 70.78% to $2.2 million in 2025, then rose by 4.85% to $2.3 million in 2026.
- According to Business Quant data, Convertible Debt over the past three periods registered $2.3 million, $2.2 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alto Neuroscience | 1.13 Bn | 1.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |